TANG CAPITAL MANAGEMENT LLC Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$219.6B
Holdings
15
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRTXHERON THERAPEUTICS INC | 5,190,837 | $98.6B | 44.89% | |
| 2 | —LA JOLLA PHARMACEUTICAL CO | 3,052,130 | $63.8B | 29.06% | |
| 3 | OPK 3 02/01/33 AIOPKO HEALTH INC | 14,000,000 | $21.8B | 9.94% | |
| 4 | BMRNBIOMARIN PHARMACEUTICAL INC | 90,215 | $7.4B | 3.39% | |
| 5 | —MERRIMACK PHARMACEUTICALS INC | 3,500,000 | $5.2B | 2.38% | |
| 6 | SRPTSAREPTA THERAPEUTICS INC | 250,000 | $4.9B | 2.22% | |
| 7 | BABAALIBABA GROUP HLDG LTD | 60,000 | $4.7B | 2.16% | |
| 8 | OPKOPKO HEALTH INC | 350,000 | $3.6B | 1.66% | |
| 9 | NKTREURNEKTAR THERAPEUTICS | 260,000 | $3.6B | 1.63% | |
| 10 | INFIQINFINITY PHARMACEUTICALS INC | 460,000 | $2.4B | 1.10% | |
| 11 | BCRXBIOCRYST PHARMACEUTICALS | 430,000 | $1.2B | 0.55% | |
| 12 | —LIPOCINE INC | 100,000 | $1.0B | 0.46% | |
| 13 | —ATYR PHARMA INC | 190,000 | $749.0M | 0.34% | |
| 14 | —IGNYTA INC | 40,000 | $271.0M | 0.12% | |
| 15 | —CELLDEX THERAPEUTICS INC | 50,000 | $189.0M | 0.09% |